Form 8-K - Current report:
SEC Accession No. 0001493152-23-039342
Filing Date
2023-11-03
Accepted
2023-11-03 16:52:35
Documents
13
Period of Report
2023-11-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44480
  Complete submission text file 0001493152-23-039342.txt   266226

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20231103.xsd EX-101.SCH 3944
3 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20231103_def.xml EX-101.DEF 26962
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20231103_lab.xml EX-101.LAB 37183
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20231103_pre.xml EX-101.PRE 25582
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6080
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 231377109
SIC: 2834 Pharmaceutical Preparations